Model Number 7300TFX |
Device Problems
Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
|
Patient Problems
Endocarditis (1834); Insufficient Information (4580)
|
Event Date 12/15/2023 |
Event Type
Injury
|
Event Description
|
It was learned through implant patient registry that a patient with a 29mm 7300tfx mitral valve was explanted after an implant duration of 4 months, 4 days due to unknown reason.The explanted valve was replaced with a 31mm 7300tfx valve.Edwards lifesciences maintains an implant patient registry.This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital, and patient family members) and is not received in the form of a conventional customer complaint.The information reported may or may not be related to the edwards device.
|
|
Manufacturer Narrative
|
The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
|
Event Description
|
It was learned through implant patient registry and investigation that a patient with a 29mm 7300tfx mitral valve was medically treated for chlamydia pneumoniae infective endocarditis/vegetation with severe paravalvular regurgitation after implant duration of approximately 1 month.The valve was explanted after a implant duration of 4 months due to continued endocarditis and dehiscence.The valve was replaced with a 31mm 7300tfx valve.Per medical records, the patient presented with infective endocarditis, initial echo showed mitral valve rocking, small mobile mass on anterior/posterior leaflets consistent with vegetation, and severe pvl.History of iv drug abuse and noncompliance.The patient was discharged with 6 weeks of doxycycline for chlamydia pneumoniae.He was re-admitted approximately 2 months later, presented with exacerbation of chf and mitral valve was found to have dehisced.Consider non-compliance vs resistance as cause for increased titers.The patient underwent redo mvr with bovine pericardium patch reconstruction of the annulus.A 31mm 7300tfx was implanted and secured with cor-knots.The chest was left open due to coagulopathy, and he was transferred to the icu in stable condition.Per id doctor, completed a course iv ceftriaxone, continue on doxycycline po at least 6 months after cardiac surgery, consider lifelong therapy.The patient was discharged on pod #18.
|
|
Manufacturer Narrative
|
Per edwards microbiology report, chlamydia pnuemoniae organism is predominantly from respiratory infection and the sealed package containing this bioprosthetic valve was not the source of infection.H11 corrected data: based on the additional information obtained, this event is no longer considered reportable and this correction is being submitted.
|
|
Search Alerts/Recalls
|
|